Obstetrical & Gynecological Survey最新文献

{"title":"Contraceptive Use in Breast Cancer Patients and Survivors.","authors":"Maya Blasingame, Jeffrey A Kuller, Sarah K Dotters-Katz, Kathryn Trotter, Nicole Kerner","doi":"10.1097/OGX.0000000000001441","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001441","url":null,"abstract":"<p><strong>Importance: </strong>Breast cancer is one of the most common malignancies among women globally, with significant implications for reproductive health, including the use of contraception. The intersection of breast cancer and contraception presents unique challenges due to concerns about cancer recurrence, patient safety, and hormonal roles in cancer. The hormonal sensitivity of many breast cancers creates a complex approach to safe contraceptive options for patients. However, recent studies highlight the nuanced role of low-dose and nonestrogenic hormonal options, such as progestin-only methods, while emphasizing the need for further research on their long-term safety.</p><p><strong>Objectives: </strong>An important aspect of breast cancer survivorship is addressed: reproductive health and contraceptive choices.</p><p><strong>Evidence acquisition: </strong>A PubMed review was conducted using terms \"breast cancer\" AND \"contraception\" OR \"contraceptive use.\" The search included review articles, original research databases, and guidelines on contraception for breast cancer patients and survivors.</p><p><strong>Results: </strong>Nonhormonal contraceptives, including copper intrauterine devices, barrier methods, and sterilization, provide safe and effective alternatives but may be less preferred by some patients due to side effects or other limitations. Current guidelines may not offer specific recommendations for both breast cancer patients and breast cancer survivors.</p><p><strong>Conclusions: </strong>A comprehensive counseling approach to address fertility in patients with breast cancer and survivors is most appropriate; nonhormonal contraceptive options provide the safest methods for patients.</p><p><strong>Relevance: </strong>Current guidelines may not offer specific recommendations for both breast cancer patients and breast cancer survivors.</p><p><strong>Target audience: </strong>Obstetricians and gynecologists, family physicians.</p><p><strong>Learning objectives: </strong>After completing this activity, the learner will be better able to describe the unique contraceptive needs for breast cancer patients and survivors; discuss the safety and efficacy of various contraceptive options for patients; and identify gaps in current contraceptive guidelines for patients and survivors.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"711-716"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Induction of Labour Versus Standard Care to Prevent Shoulder Dystocia in Fetuses Suspected to Be Large for Gestational Age in the UK (the Big Baby Trial): A Multicentre, Open-Label, Randomized Controlled Trial.","authors":"Jason Gardosi, Lauren Jade Ewington, Katie Booth, Debra Bick, George Bouliotis, Emily Butler, Sanjeev Deshpande, Hanna Ellson, Joanne Fisher, Adam Gornall, Ranjit Lall, Hema Mistry, Seyran Naghdi, Stavros Petrou, Anne-Marie Slowther, Sara Wood, Martin Underwood, Siobhan Quenby","doi":"10.1097/OGX.0000000000001465","DOIUrl":"10.1097/OGX.0000000000001465","url":null,"abstract":"<p><p>(Abstracted from Lancet 2024;405:1743-1756) Shoulder dystocia is associated with several maternal and neonatal complications and is a common reason for litigation in obstetrics. Maternal complications include hemorrhage and third- and fourth-degree perineal severe tears; neonatal complications include fractures, brachial plexus injury, hypoxic ischemic encephalopathy, and neonatal death.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"677-679"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.","authors":"Liqiu Kou, Changyou Huang, Di Xiao, Songjie Liao, Yaling Li, Qing Wang","doi":"10.1097/OGX.0000000000001460","DOIUrl":"10.1097/OGX.0000000000001460","url":null,"abstract":"<p><p>(Abstracted from Obstet Gynecol 2025;146(2):e23-e35) An estimated 10% to 15% of women who are of reproductive age are affected by endometriosis, defined as abnormal growth of endometrium-like tissue outside of the uterus. Symptoms can include cyclical or noncyclical abdominal pain, pain during intercourse, excessive menstruation, infertility, and others.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"697-699"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Birth Outcomes Among Women With Syphilis During Pregnancy in Six U.S. States, 2018-2021.","authors":"Jeffrey M Carlson, Christina L Sancken, Khue Nguyen, Elizabeth L Lewis, Aisha Praag, Kourtney Pulliam, Teri' Willabus, Zacharie Eric Bakwa, Nicole D Longcore, Kevin P O'Callaghan, Kathryn Miele, Alison Fountain, Van T Tong, Kate R Woodworth","doi":"10.1097/01.ogx.0001172292.66135.2a","DOIUrl":"10.1097/01.ogx.0001172292.66135.2a","url":null,"abstract":"<p><p>(Abstracted from Obstet Gynecol 2025;146:121-128) Syphilis during pregnancy has long been linked to poor maternal and fetal outcomes, including stillbirth, prematurity, neonatal intensive care unit (NICU) admission, and increased health care costs. With rates of both maternal and congenital syphilis rising over the past decade, there is a strong need for updated data on adverse outcomes in pregnancies affected by syphilis.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"691-693"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prenatal Screening for CMV Primary Infection: A Cost-Utility Model.","authors":"Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran","doi":"10.1097/01.ogx.0001172288.00818.27","DOIUrl":"https://doi.org/10.1097/01.ogx.0001172288.00818.27","url":null,"abstract":"<p><p>(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"689-691"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"First Trimester Maternal Folate and Vitamin B12 Concentrations and Their Associations With First-Trimester Placental Growth: The Rotterdam Periconception Cohort.","authors":"M M Van Vliet, S Schoenmakers, S P Willemsen, K D Sinclair, R P M Steegers-Theunissen","doi":"10.1097/OGX.0000000000001461","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001461","url":null,"abstract":"<p><p>(Abstracted from Hum Reprod 2025 ;40(8):1485-1494) Embryonic development relies heavily on 1-carbon metabolism, which is influenced heavily by folate and vitamin B12. Both placental and embryonic and fetal development are affected, and previous research has shown supplementation with folic acid during early pregnancy reduces the prevalence of neural tube defects; some research has also shown that deficiencies in folate and vitamin B12 may be associated with adverse pregnancy outcomes such as preeclampsia and low birth weight.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"704-706"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.","authors":"Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck","doi":"10.1097/OGX.0000000000001463","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001463","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"681-683"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.","authors":"Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck","doi":"10.1097/OGX.0000000000001463","DOIUrl":"10.1097/OGX.0000000000001463","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"681-683"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prenatal Screening for CMV Primary Infection: A Cost-Utility Model.","authors":"Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran","doi":"10.1097/01.ogx.0001172288.00818.27","DOIUrl":"10.1097/01.ogx.0001172288.00818.27","url":null,"abstract":"<p><p>(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"689-691"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perinatal Outcomes Following Nonadherence to Guideline-Based Screening for Gestational Diabetes: A Population-Based Cohort Study.","authors":"Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A Hutcheon, Patricia A Janssen, Laura Schummers","doi":"10.1097/01.ogx.0001172280.42312.99","DOIUrl":"10.1097/01.ogx.0001172280.42312.99","url":null,"abstract":"<p><p>(Abstracted from Acta Obstet Gynecol Scand 2025;104:839-849) Gestational diabetes mellitus (GDM), defined as high blood sugar onset in pregnancy, is associated with adverse outcomes and increased long-term maternal diabetes risk. Screening protocols vary internationally, with some countries testing only high-risk pregnancies, but Canada has recommended universal screening since 2003.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"683-685"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}